Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, pathways, authors, ontology terms, etc. (e.g. eve, embryo, zen, allele)
  • Use OR to search for either of two terms (e.g. fly OR drosophila) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. dros* for partial matches or fly AND NOT embryo to exclude a term

Search results 3801 to 3900 out of 44733 for *

Category restricted to GOTerm (x)

<< First    < Previous  |  Next >    Last >>
0.024s

Categories

Category: GOTerm
« show all
Type Details Score
GO Term
GO:0002012 | vasoconstriction of artery involved in chemoreceptor response to lowering of systemic arterial blood pressure
Description: A process that is triggered by vasomotor excitation and results in a decrease in the diameter of an artery during the chemoreceptor response to decreased blood pressure.
•
•
•
•
•
GO Term
GO:0002013 | detection of carbon dioxide by vasomotor center
Description: The process by a carbon dioxide stimulus is received and converted to a molecular signal by the vasomotor center of the central nervous system.
•
•
•
•
•
GO Term
GO:0003031 | detection of carbon dioxide
Description: The series of events in which a carbon dioxide stimulus is received by a cell and converted into a molecular signal.
•
•
•
•
•
GO Term
GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure
Description: The vasoconstriction that is triggered by vasomotor excitation resulting from the detection of high carbon dioxide levels in the vasomotor center of the central nervous system.
•
•
•
•
•
GO Term
GO:0002015 | regulation of systemic arterial blood pressure by atrial baroreceptor feedback
Description: A process that controls blood pressure by sensing the amount of stretch occurring in the atria.
•
•
•
•
•
GO Term
GO:0002016 | regulation of blood volume by renin-angiotensin
Description: The process in which the renin-angiotensin system controls the rate of fluid intake and output into the blood.
•
•
•
•
•
GO Term
GO:0002017 | regulation of blood volume by renal aldosterone
Description: The process in which the hormone aldosterone decreases the rate of diuresis and natriuresis resulting in increased blood volume.
•
•
•
•
•
GO Term
GO:0002018 | renin-angiotensin regulation of aldosterone production
Description: The process in which an increase in active angiotensin stimulates the adrenal cortices to secrete aldosterone.
•
•
•
•
•
GO Term
GO:2000858 | regulation of aldosterone secretion
Description: Any process that modulates the frequency, rate or extent of aldosterone secretion.
•
•
•
•
•
GO Term
GO:0060986 | endocrine hormone secretion
Description: The regulated release of a hormone into the circulatory system.
•
•
•
•
•
GO Term
GO:2000846 | regulation of corticosteroid hormone secretion
Description: Any process that modulates the frequency, rate or extent of corticosteroid hormone secretion.
•
•
•
•
•
GO Term
GO:0140353 | lipid export from cell
Description: The directed movement of a lipid from a cell, into the extracellular region.
•
•
•
•
•
GO Term
GO:0032368 | regulation of lipid transport
Description: Any process that modulates the frequency, rate or extent of the directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0044060 | regulation of endocrine process
Description: Any process that modulates the frequency, rate or extent of an endocrine process, a process involving the secretion of or response to endocrine hormones. An endocrine hormone is a hormone released into the circulatory system.
•
•
•
•
•
GO Term
GO:2000855 | regulation of mineralocorticoid secretion
Description: Any process that modulates the frequency, rate or extent of mineralocorticoid secretion.
•
•
•
•
•
GO Term
GO:1905952 | regulation of lipid localization
Description: Any process that modulates the frequency, rate or extent of lipid localization.
•
•
•
•
•
GO Term
GO:0035929 | steroid hormone secretion
Description: The regulated release of any steroid that acts as a hormone into the circulatory system.
•
•
•
•
•
GO Term
GO:0035930 | corticosteroid hormone secretion
Description: The regulated release of any corticosteroid hormone into the circulatory system.
•
•
•
•
•
GO Term
GO:0035932 | aldosterone secretion
Description: The regulated release of aldosterone into the circulatory system. Aldosterone is a pregnane-based steroid hormone produced by the outer-section (zona glomerulosa) of the adrenal cortex in the adrenal gland, and acts on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure. The overall effect of aldosterone is to increase reabsorption of ions and water in the kidney.
•
•
•
•
•
GO Term
GO:0035931 | mineralocorticoid secretion
Description: The regulated release of any mineralocorticoid into the circulatory system. Mineralocorticoids are a class of steroid hormones that regulate water and electrolyte metabolism.
•
•
•
•
•
GO Term
GO:2000831 | regulation of steroid hormone secretion
Description: Any process that modulates the frequency, rate or extent of steroid hormone secretion.
•
•
•
•
•
GO Term
GO:0002019 | regulation of renal output by angiotensin
Description: The process in which angiotensin directly modulates the rate of urine output by the kidney.
•
•
•
•
•
GO Term
GO:0002021 | response to dietary excess
Description: The physiological process in which dietary excess is sensed by the central nervous system, resulting in a reduction in food intake and increased energy expenditure.
•
•
•
•
•
GO Term
GO:0002022 | detection of dietary excess
Description: The neurological process in which the brain senses excessive caloric intake.
•
•
•
•
•
GO Term
GO:0002023 | reduction of food intake in response to dietary excess
Description: An eating behavior process whereby detection of a dietary excess results in a decrease in intake of nutrients.
•
•
•
•
•
GO Term
GO:0042755 | eating behavior
Description: The specific behavior of an organism relating to the intake of food, any substance (usually solid) that can be metabolized by an organism to give energy and build tissue.
•
•
•
•
•
GO Term
GO:0002024 | diet induced thermogenesis
Description: The process that results in increased metabolic rate in tissues of an organism. It is triggered by the detection of dietary excess. This process is achieved via signalling in the sympathetic nervous system.
•
•
•
•
•
GO Term
GO:1990845 | adaptive thermogenesis
Description: The regulated production of heat in response to short term environmental changes, such as stress, diet or reduced temperature.
•
•
•
•
•
GO Term
GO:0002025 | norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure
Description: A process that results in an increase in the diameter of an artery during the norepinephrine-epinephrine response to blood pressure change.
•
•
•
•
•
GO Term
GO:0015672 | monovalent inorganic cation transport
Description: The directed movement of inorganic cations with a valency of one into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Inorganic cations are atoms or small molecules with a positive charge which do not contain carbon in covalent linkage.
•
•
•
•
•
GO Term
GO:0045744 | negative regulation of G protein-coupled receptor signaling pathway
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of G protein-coupled receptor signaling pathway.
•
•
•
•
•
GO Term
GO:0002029 | desensitization of G protein-coupled receptor signaling pathway
Description: The process that stops, prevents, or reduces the frequency, rate or extent of G protein-coupled receptor signaling pathway after prolonged stimulation with an agonist of the pathway.
•
•
•
•
•
GO Term
GO:0002030 | inhibitory G protein-coupled receptor phosphorylation
Description: The process that inhibits the signaling function of a G protein-coupled receptor by addition of a phosphate group to its third intracellular loop consensus site.
•
•
•
•
•
GO Term
GO:0002031 | G protein-coupled receptor internalization
Description: The process that results in the uptake of a G protein-coupled receptor into an endocytic vesicle.
•
•
•
•
•
GO Term
GO:0002032 | desensitization of G protein-coupled receptor signaling pathway by arrestin
Description: The process that inhibits the signaling function of a G protein-coupled receptor by uncoupling the receptor from its downstream G proteins.
•
•
•
•
•
GO Term
GO:0032091 | negative regulation of protein binding
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
•
•
•
•
•
GO Term
GO:0051100 | negative regulation of binding
Description: Any process that stops or reduces the rate or extent of binding, the selective interaction of a molecule with one or more specific sites on another molecule.
•
•
•
•
•
GO Term
GO:0051098 | regulation of binding
Description: Any process that modulates the frequency, rate or extent of binding, the selective interaction of a molecule with one or more specific sites on another molecule.
•
•
•
•
•
GO Term
GO:0043393 | regulation of protein binding
Description: Any process that modulates the frequency, rate or extent of protein binding.
•
•
•
•
•
GO Term
GO:0002033 | angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure
Description: The process that increases the diameter of a blood vessel via the renin-angiotensin system.
•
•
•
•
•
GO Term
GO:0002035 | brain renin-angiotensin system
Description: The process in which an angiotensin-mediated signaling system present in the brain regulates the force with which blood passes through the circulatory system.
•
•
•
•
•
GO Term
GO:2001023 | regulation of response to drug
Description: Any process that modulates the frequency, rate or extent of response to drug.
•
•
•
•
•
GO Term
GO:0002036 | regulation of L-glutamate import across plasma membrane
Description: Any process that modulates the frequency, rate or extent of L-glutamate import into a cell.
•
•
•
•
•
GO Term
GO:0051580 | regulation of neurotransmitter uptake
Description: Any process that modulates the frequency, rate or extent of the directed movement of a neurotransmitter into a neuron or glial cell.
•
•
•
•
•
GO Term
GO:0010958 | regulation of amino acid import across plasma membrane
Description: Any process that modulates the frequency, rate or extent of amino acid import into a cell.
•
•
•
•
•
GO Term
GO:0098712 | L-glutamate import across plasma membrane
Description: The directed movement of L-glutamate from outside of a cell, across the plasma membrane and into the cytosol.
•
•
•
•
•
GO Term
GO:0098739 | import across plasma membrane
Description: The directed movement of some substance from outside of a cell, across the plasma membrane and into the cytosol.
•
•
•
•
•
GO Term
GO:0015837 | amine transport
Description: The directed movement of amines, including polyamines, organic compounds containing one or more amino groups, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0051938 | L-glutamate import
Description: The directed movement of L-glutamate, the L-enantiomer of the anion of 2-aminopentanedioic acid, into a cell or organelle.
•
•
•
•
•
GO Term
GO:0089718 | amino acid import across plasma membrane
Description: The directed movement of an amino acid from outside of a cell, across the plasma membrane and into the cytosol.
•
•
•
•
•
GO Term
GO:0032890 | regulation of organic acid transport
Description: Any process that modulates the frequency, rate or extent of the directed movement of organic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:1903959 | regulation of anion transmembrane transport
Description: Any process that modulates the frequency, rate or extent of anion transmembrane transport.
•
•
•
•
•
GO Term
GO:0015800 | acidic amino acid transport
Description: The directed movement of acidic amino acids, amino acids with a pH below 7, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0051955 | regulation of amino acid transport
Description: Any process that modulates the frequency, rate or extent of the directed movement of amino acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0051952 | regulation of amine transport
Description: Any process that modulates the frequency, rate or extent of the directed movement of amines into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:1903789 | regulation of amino acid transmembrane transport
Description: Any process that modulates the frequency, rate or extent of amino acid transmembrane transport.
•
•
•
•
•
GO Term
GO:0043090 | amino acid import
Description: The directed movement of amino acids into a cell or organelle.
•
•
•
•
•
GO Term
GO:0051956 | negative regulation of amino acid transport
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of amino acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0002037 | negative regulation of L-glutamate import across plasma membrane
Description: Any process that stops, prevents or reduces the frequency, rate or extent of L-glutamate import into a cell.
•
•
•
•
•
GO Term
GO:1903960 | negative regulation of anion transmembrane transport
Description: Any process that stops, prevents or reduces the frequency, rate or extent of anion transmembrane transport.
•
•
•
•
•
GO Term
GO:2001024 | negative regulation of response to drug
Description: Any process that stops, prevents or reduces the frequency, rate or extent of response to drug.
•
•
•
•
•
GO Term
GO:0051581 | negative regulation of neurotransmitter uptake
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a neurotransmitter into a neuron or glial cell.
•
•
•
•
•
GO Term
GO:0051589 | negative regulation of neurotransmitter transport
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a neurotransmitter into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0043271 | negative regulation of ion transport
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0032891 | negative regulation of organic acid transport
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of organic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:1903792 | negative regulation of anion transport
Description: Any process that stops, prevents or reduces the frequency, rate or extent of anion transport.
•
•
•
•
•
GO Term
GO:0051953 | negative regulation of amine transport
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of amines into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0034766 | negative regulation of ion transmembrane transport
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of ions from one side of a membrane to the other.
•
•
•
•
•
GO Term
GO:0034763 | negative regulation of transmembrane transport
Description: Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of a solute from one side of a membrane to the other.
•
•
•
•
•
GO Term
GO:1903961 | positive regulation of anion transmembrane transport
Description: Any process that activates or increases the frequency, rate or extent of anion transmembrane transport.
•
•
•
•
•
GO Term
GO:0002038 | positive regulation of L-glutamate import across plasma membrane
Description: Any process that activates or increases the frequency, rate or extent of L-glutamate import into a cell.
•
•
•
•
•
GO Term
GO:2001025 | positive regulation of response to drug
Description: Any process that activates or increases the frequency, rate or extent of response to drug.
•
•
•
•
•
GO Term
GO:0051957 | positive regulation of amino acid transport
Description: Any process that activates, maintains or increases the frequency, rate or extent of the directed movement of amino acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0051582 | positive regulation of neurotransmitter uptake
Description: Any process that activates or increases the frequency, rate or extent of the directed movement of a neurotransmitter into a neuron or glial cell.
•
•
•
•
•
GO Term
GO:0032892 | positive regulation of organic acid transport
Description: Any process that activates or increases the frequency, rate or extent of the directed movement of organic acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:1903793 | positive regulation of anion transport
Description: Any process that activates or increases the frequency, rate or extent of anion transport.
•
•
•
•
•
GO Term
GO:0051954 | positive regulation of amine transport
Description: Any process that activates, maintains or increases the frequency, rate or extent of the directed movement of amines into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
•
•
•
•
•
GO Term
GO:0002041 | intussusceptive angiogenesis
Description: The formation of new blood vessels as a result of the insertion and extension of lumenal tissue pillars.
•
•
•
•
•
GO Term
GO:0043534 | blood vessel endothelial cell migration
Description: The orderly movement of an endothelial cell into the extracellular matrix in order to form new blood vessels during angiogenesis.
•
•
•
•
•
GO Term
GO:0002042 | cell migration involved in sprouting angiogenesis
Description: The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels involved in sprouting angiogenesis.
•
•
•
•
•
GO Term
GO:0010631 | epithelial cell migration
Description: The orderly movement of an epithelial cell from one site to another, often during the development of a multicellular organism.
•
•
•
•
•
GO Term
GO:0090130 | tissue migration
Description: The process in which the population of cells that make up a tissue undergo directed movement.
•
•
•
•
•
GO Term
GO:0090132 | epithelium migration
Description: The process in which the population of cells that make up an epithelium undergo directed movement.
•
•
•
•
•
GO Term
GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis
Description: The multiplication or reproduction of blood vessel endothelial cells, resulting in the expansion of a cell population contributing to sprouting angiogenesis.
•
•
•
•
•
GO Term
GO:0002044 | blood vessel endothelial cell migration involved in intussusceptive angiogenesis
Description: The orderly movement of endothelial cells into the extracellular matrix in order to form new blood vessels during intussusceptive angiogenesis.
•
•
•
•
•
GO Term
GO:0002045 | regulation of cell adhesion involved in intussusceptive angiogenesis
Description: The process that modulates the frequency, rate or extent of attachment of a blood vessel endothelial cell to another cell or to the extracellular matrix involved in intussusceptive angiogenesis.
•
•
•
•
•
GO Term
GO:0002046 | opsin binding
Description: Interacting selectively and non-covalently with an opsin, any of a group of hydrophobic, integral membrane glycoproteins located primarily in the disc membrane of rods or cones, involved in photoreception.
•
•
•
•
•
GO Term
GO:0002047 | phenazine biosynthetic process
Description: The chemical reactions and pathways resulting in the formation of a phenazine antibiotic, a polycyclic pyrazine with two nitrogen atoms in the ring.
•
•
•
•
•
GO Term
GO:0016999 | antibiotic metabolic process
Description: The chemical reactions and pathways involving an antibiotic, a substance produced by or derived from certain fungi, bacteria, and other organisms, that can destroy or inhibit the growth of other microorganisms.
•
•
•
•
•
GO Term
GO:0002048 | pyoverdine metabolic process
Description: The chemical reactions and pathways involving the siderochrome pyoverdine.
•
•
•
•
•
GO Term
GO:0051186 | cofactor metabolic process
Description: The chemical reactions and pathways involving a cofactor, a substance that is required for the activity of an enzyme or other protein. Cofactors may be inorganic, such as the metal atoms zinc, iron, and copper in certain forms, or organic, in which case they are referred to as coenzymes. Cofactors may either be bound tightly to active sites or bind loosely with the substrate.
•
•
•
•
•
GO Term
GO:0002049 | pyoverdine biosynthetic process
Description: The chemical reactions and pathways resulting in the formation of the siderochrome pyoverdine.
•
•
•
•
•
GO Term
GO:0019184 | nonribosomal peptide biosynthetic process
Description: The biosynthetic process in which peptide bond formation occurs in the absence of the translational machinery. Examples include the synthesis of antibiotic peptides, and glutathione.
•
•
•
•
•
GO Term
GO:0046215 | siderophore catabolic process
Description: The chemical reactions and pathways resulting in the breakdown of siderophores, low molecular weight Fe(III)-chelating substances made by aerobic or facultatively anaerobic bacteria, especially when growing under iron deficient conditions. The complexes of Fe(3+)-siderophores have very high stability constants and are taken up by specific transport systems by microorganisms; the subsequent release of iron requires enzymatic action.
•
•
•
•
•
GO Term
GO:0002050 | pyoverdine catabolic process
Description: The chemical reactions and pathways resulting in the breakdown of the siderochrome pyoverdine.
•
•
•
•
•
GO Term
GO:0051187 | cofactor catabolic process
Description: The chemical reactions and pathways resulting in the breakdown of a cofactor, a substance that is required for the activity of an enzyme or other protein.
•
•
•
•
•
GO Term
GO:0090487 | secondary metabolite catabolic process
Description: The chemical reactions and pathways resulting in the breakdown of secondary metabolites, the compounds that are not necessarily required for growth and maintenance of cells, and are often unique to a taxon.
•
•
•
•
•
GO Term
GO:0002051 | osteoblast fate commitment
Description: The commitment of mesenchymal cells to the specific cell fate of an osteoblast. An osteoblast is a bone-forming cell which secretes an extracellular matrix. Hydroxyapatite crystals are then deposited into the matrix to form bone.
•
•
•
•
•
GO Term
GO:1902692 | regulation of neuroblast proliferation
Description: Any process that modulates the frequency, rate or extent of neuroblast proliferation.
•
•
•
•
•
GO Term
GO:0002052 | positive regulation of neuroblast proliferation
Description: Any process that activates or increases the rate of neuroblast proliferation.
•
•
•
•
•
USDA
InterMine logo
The Legume Information System (LIS) is a research project of the USDA-ARS:Corn Insects and Crop Genetics Research in Ames, IA.
LegumeMine || ArachisMine | CicerMine | GlycineMine | LensMine | LupinusMine | PhaseolusMine | VignaMine | MedicagoMine
InterMine © 2002 - 2022 Department of Genetics, University of Cambridge, Downing Street, Cambridge CB2 3EH, United Kingdom